Sunbelt Securities’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.1K Hold
1,000
﹤0.01% 1190
2025
Q4
$26.2K Hold
1,000
﹤0.01% 1178
2025
Q3
$23.6K Sell
1,000
-100
-9% -$2.21K ﹤0.01% 1215
2025
Q2
$24.9K Buy
1,100
+100
+10% +$2.01K ﹤0.01% 1112
2025
Q1
$20.5K Sell
1,000
-100
-9% -$2.23K ﹤0.01% 1120
2024
Q4
$24.8K Hold
1,100
﹤0.01% 1112
2024
Q3
$27.1K Hold
1,100
﹤0.01% 1087
2024
Q2
$25.4K Hold
1,100
﹤0.01% 1065
2024
Q1
$26.5K Sell
1,100
-40
-4% -$938 ﹤0.01% 1028
2023
Q4
$26.2K Hold
1,140
﹤0.01% 965
2023
Q3
$23.2K Hold
1,140
﹤0.01% 975
2023
Q2
$26.6K Hold
1,140
﹤0.01% 943
2023
Q1
$26.1K Buy
+1,140
New +$28.5K ﹤0.01% 887

Other funds holding IDNA

Sunbelt Securities's IDNA Position: Q1 2026 in Review

Sunbelt Securities held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q1 2026 at 1,000 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Sunbelt Securities first reported a position in IDNA in Q1 2023 and has held it in 13 quarters since. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Sunbelt Securities held 1,000 shares of iShares Genomics Immunology and Healthcare ETF worth $29.1K as of Q1 2026.
  • Sunbelt Securities left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q1 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1190 holding.
  • Sunbelt Securities first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and has held it in 13 quarters since.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.